← Every applicant
Genentech Inc FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| EVRYSDINew drugFeb 11, 2025TABLET, ORAL |
| ITOVEBINew drugOct 10, 2024TABLET, ORAL |
| OCREVUS ZUNOVONew drugSep 13, 2024INJECTABLE, INJECTION |
| TECENTRIQ HYBREZANew drugSep 12, 2024INJECTABLE, INJECTION |
| PIASKYNew drugJun 20, 2024INJECTABLE, INTRAVENOUS |
| ROZLYTREKNew drugOct 20, 2023PELLETS, ORAL |
| COLUMVINew drugJun 15, 2023INJECTABLE, INJECTION |
| LUNSUMIO VELONew drugDec 22, 2022INJECTABLE, INJECTION |
| VABYSMONew drugJan 28, 2022INJECTABLE, INTRAVITREAL |
| SUSVIMONew drugOct 22, 2021SOLUTION, INJECTION |